Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Yerly

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Expert Opinion on Therapeutic Targets|November 16, 2006
Targets of emerging therapies for viral hepatitis B and CDaniel Yerly, Loriana Di Giammarino, Florian Bihl, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 16, 2022
Delayed IgE-mediated hypersensitivity to Arthrospira platensis (spirulina)Eva Pescosolido, Daniel Yerly, Jean-Christoph Caubet, et al.
Journal of Dermatological Science|March 8, 2011
Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphomaChristoph Schlapbach, Daniel Yerly, Barbara Daubner, et al.
The Journal of Allergy and Clinical Immunology|October 28, 2017
A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentationPaul Engeroff, Marc Fellmann, Daniel Yerly, et al.
Frontiers in Allergy|April 7, 2022
The Activation Pattern of Drug-Reacting T Cells Has an Impact on the Clinical Picture of Hypersensitivity ReactionsNatascha Wuillemin, Barbara Ballmer-Weber, Christoph Schlapbach, et al.
International Archives of Allergy and Immunology|November 3, 2015
Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune ReceptorsWerner J Pichler, Jacqueline Adam, Stephen Watkins, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 15, 2025
The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivityTim Peyer, Lester Thoo, Daniel Yerly, et al.
Experimental Dermatology|December 10, 2017
Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1/Th17 immune responseRahel Thomi, Christoph Schlapbach, Nikhil Yawalkar, et al.
The Medical Clinics of North America|July 9, 2010
Drug hypersensitivity reactions: pathomechanism and clinical symptomsWerner J Pichler, Jaqueline Adam, Barbara Daubner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2013
HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillinNatascha Wuillemin, Jacqueline Adam, Stefano Fontana, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Expert Opinion on Therapeutic Targets|November 16, 2006
Targets of emerging therapies for viral hepatitis B and CDaniel Yerly, Loriana Di Giammarino, Florian Bihl, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 16, 2022
Delayed IgE-mediated hypersensitivity to Arthrospira platensis (spirulina)Eva Pescosolido, Daniel Yerly, Jean-Christoph Caubet, et al.
Journal of Dermatological Science|March 8, 2011
Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphomaChristoph Schlapbach, Daniel Yerly, Barbara Daubner, et al.
The Journal of Allergy and Clinical Immunology|October 28, 2017
A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentationPaul Engeroff, Marc Fellmann, Daniel Yerly, et al.
Frontiers in Allergy|April 7, 2022
The Activation Pattern of Drug-Reacting T Cells Has an Impact on the Clinical Picture of Hypersensitivity ReactionsNatascha Wuillemin, Barbara Ballmer-Weber, Christoph Schlapbach, et al.
International Archives of Allergy and Immunology|November 3, 2015
Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune ReceptorsWerner J Pichler, Jacqueline Adam, Stephen Watkins, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 15, 2025
The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivityTim Peyer, Lester Thoo, Daniel Yerly, et al.
Experimental Dermatology|December 10, 2017
Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1/Th17 immune responseRahel Thomi, Christoph Schlapbach, Nikhil Yawalkar, et al.
The Medical Clinics of North America|July 9, 2010
Drug hypersensitivity reactions: pathomechanism and clinical symptomsWerner J Pichler, Jaqueline Adam, Barbara Daubner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2013
HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillinNatascha Wuillemin, Jacqueline Adam, Stefano Fontana, et al.
Pageof 5